The Lynx Group

Articles are edited for style and sense; all data and facts are checked for accuracy, consistency, and sense. External sources are verified and corrected if needed.

The ideas and opinions expressed in Value-Based Cancer Care® do not necessarily reflect those of the Editorial Advisory Board, the Editor, or the Publisher. Publication of an advertisement or other product mentioned in Value-Based Cancer Care® should not be construed as an endorsement of the product or manufacturers’ claims. Readers are encouraged to contact the manufacturers about any features or limitations of products mentioned. Neither the editors nor the publisher assume any responsibility for any injury and/or damage to persons or property arising out of or related to any use of the material mentioned in this publication.

Personalized Medicine | Browse By Specialty

We Want to Know

Is access to care an obstacle for patients today?


Latest Videos

Using FGFR Inhibitors in Clinical Practice Once FDA-Approved
Toxicities Associated with FGFR Inhibitors
Effective Targeted Therapies in CCA: IDH1 and FGFR

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: